IL24 and liver cancer: Additionally, in the MHCC97-H xenograft liver cancer model, combination treatment resulted in significant tumor reduction compared to a single treatment, exhibiting the synergistic mechanism employed by VV-IL-24 and Luteolin to treat liver cancer [114].